Biovitamins Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 05-07-2024
- Paid Up Capital ₹ 2.50 M
as on 05-07-2024
- Company Age 22 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 65143.90%
(FY 2023)
- Profit 34167.41%
(FY 2023)
- Ebitda 51140.34%
(FY 2023)
- Net Worth 106008.39%
(FY 2023)
- Total Assets 115231.44%
(FY 2023)
About Biovitamins
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Yelavarthi Raju and Anupama serve as directors at the Company.
- CIN/LLPIN
U24234KA2002PTC030453
- Company No.
030453
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 May 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biovitamins Private Limited offer?
Biovitamins Private Limited offers a wide range of products and services, including Healthcare Products & Aids, Health Drinks, Nutraceuticals, Nutritional Supplements, Vitamin Tablets & Capsules, Protein Powder, Kids Protein Powder, Dinnerware and Serving Utensils, Serving Utensils, Ayurvedic,Herbal Products & Medicine.
Who are the key members and board of directors at Biovitamins?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yelavarthi Raju  | Managing Director | 03-May-2002 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anupama | Director | 14-Mar-2020 | Current |
Financial Performance of Biovitamins.
Biovitamins Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 65143.9% increase. The company also saw a substantial improvement in profitability, with a 34167.41% increase in profit. The company's net worth Soared by an impressive increase of 106008.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biovitamins?
Unlock access to Biovitamins's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biovitamins?
Biovitamins has a workforce of 137 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biovitamins, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biovitamins's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
